Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

05 Nov 2025 07:01 CET

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1368911_PR_AmPORE_TB_Announcement_ONT__bioMrieux_20251105.pdf